In a study of prostate cancers, Smurf2 mRNA levels were lower in advanced tumors compared to less advanced organ-confined tumors, suggesting an association of Smurf2 downregulation with tumor progression [27]. This evidence concerns the gene SMURF2 and prostate carcinoma.